Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Inhibition of Cathepsin B (unknown origin) at 0.00001 M relative to control
Assay data:3 Tested
SummaryRelated BioAssays by Target
Inhibition of human cathepsin B
Assay data:25 Tested
Inhibition of human Cathepsin B using Z-Arg-Arg-AM as substrate at 3 microM relative to control
Assay data:1 Tested
Inhibition of human cathepsin B endopeptidase activity at 50 uM relative to control
Inhibition of human cathepsin B exopeptidase activity at 50 uM relative to control
Assay data:8 Tested
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
Binding affinity to Cathepsin B (unknown origin) assessed as inhibition constant
Assay data:2 Active, 2 Tested
Inhibition of Cathepsin B (unknown origin) assessed as inhibition of AFC release using sequence RR labelled with AFC as substrate by fluorescence based analysis
Assay data:1 Active, 5 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Inhibition of human recombinant Cathepsin B using Z-Leu-Arg-AMC as substrate pretreated for 60 mins followed by substrate addition and incubated for 30 mins by microplate reader assay
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of human liver cathepsin B at 100 uM using Boc-Leu-Arg-Arg-AMC as substrate preincubated for 15 mins followed by substrate addition measured after 30 mins by measuring amount of AMC formed by spectrofluorimetric method
Inhibition of human liver cathepsin B using Boc-Leu-Arg-Arg-AMC as substrate preincubated for 15 mins followed by substrate addition measured after 30 mins by measuring amount of AMC formed by spectrofluorimetric method
Inhibition of recombinant human Cathepsin B expressed in human A549 using Z-Phe-Arg-AMC as substrate followed by CA-074 addition incubated for 30 mins by fluorometric assay
Inhibition of recombinant human Cathepsin B expressed in huamn A549 using Z-Phe-Arg-AMC as substrate incubated for 30 mins by fluorometric assay
Assay data:1 Active, 1 Tested
Inhibition of recombinant human Cathepsin B expressed in African green monkey Vero E6 using Z-Phe-Arg-AMC as substrate followed by CA-074 addition incubated for 30 mins by fluorometric assay
Inhibition of recombinant human Cathepsin B in African green monkey Vero E6 using Z-Phe-Arg-AMC as substrate for 30 mins by fluorometric assay
Inhibition of human recombinant Cathepsin B assessed as ratio of Kinact/Kiapp using Z-FR-AMC as substrate inubated for 30 mins by fluorometric assay
Assay data:5 Tested
Inhibition of human recombinant Cathepsin B assessed as Apparent inhibition constant using Z-FR-AMC as substrate inubated for 30 mins by fluorometric assay
Assay data:5 Active, 5 Activity ≤ 1 µM, 5 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Inhibition of human recombinant Cathepsin B assessed as Kinact using Z-FR-AMC as substrate inubated for 30 mins by fluorometric assay
Inhibition of human recombinant Cathepsin B assessed remaining activity using Z-FR-AMC as substrate incubated for 30 mins by fluorometric assay
Assay data:1 Active, 1 Activity ≤ 1 µM, 5 Tested
Inhibition of human cathepsin B incubated for 30 mins by fluorometric analysis
Assay data:3 Active, 2 Activity ≤ 1 µM, 3 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on